Replies to post #4388 on Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[tjguy]

Only things I can think of might be:
1. last minute safety concerns -- virtually impossible as both compounds are FDA approved
2. manufacturing issues that cause a major delay -- improbable with their Israeli partner ?

OK, let's brainstorm a bit here. First of all, biotech itself could crash again like it did last year. We've had 3 down days here. Hopefully that will reverse itself soon.

Another possible downer would be Hillary elected - if she says or does something to impugn biotech stocks. That is a real possibility. We're still going to make money, but maybe just not as much?

There could be some kind of an overall market crash. Again, with KTOV's upcoming catalysts, I'd rather be in this stock if that happens than another stock, but it would certainly eat away at some of our profits.

I don't see any manufacturing issues causing a delay as these guys are the largest private drug manufacturer in Israel - very reliable, but anything is possible.

Although it seems unlikely, a CRL is not out of the question with the current FDA administration. Again, I doubt it, but until it is approved, nothing is certain. I'm gambling on approval though.